首页 | 本学科首页   官方微博 | 高级检索  
检索        

影响泌乳素型垂体腺瘤患者服药依从性的原因及对策
引用本文:王静,李环廷,谢宏伟,窦娴丽.影响泌乳素型垂体腺瘤患者服药依从性的原因及对策[J].青岛医药卫生,2009,41(1):9-10.
作者姓名:王静  李环廷  谢宏伟  窦娴丽
作者单位:青岛大学医学院附属医院,266003
摘    要:目的分析影响泌乳素型垂体腺瘤患者服药依从性的原因并提出相应对策,以提高服药依从性。方法调查分析97例口服溴隐亭治疗泌乳素型垂体腺瘤患者服药依从性下降的原因。结果97位患者服药依从性良好42例,下降55例。依从性下降的原因包括相关知识缺乏、错误21例(38.2%)、药物副作用15例(27.3%)、经济原因13例(23.6%)、溴隐亭抵抗6例(10.9%)。结论口服溴隐亭治疗泌乳素型垂体腺瘤患者服药依从性下降的原因较多:针对性的对策可提高患者服药依从性。

关 键 词:泌乳素型垂体腺瘤  溴隐亭  依从性

Causes for Bad Compliance on Taking Bromocriptine in Patients with Macroprolactinomas and the Counterplans
Wang Jing,et al..Causes for Bad Compliance on Taking Bromocriptine in Patients with Macroprolactinomas and the Counterplans[J].QINGDAO Medical Journal,2009,41(1):9-10.
Authors:Wang Jing  
Institution:Wang Jing,et al.Affiliated Hospital of Medical College,Qingdao University.Qingdao,266003
Abstract:Objective To investigate the causes for bad compliance on taking bromocriptine in patients with macroprolactinomas and to put forward corresponding counterplans. Methods The causes for bad compliance of 97 cases of macroprolactinomas with oral bromocriptine were investigated. Results The causes for affecting compliance were as follows: the absence and error of correlative knowledge(38.2%), side-effects(27.3%),economy(23.6%), bromocriptine resistance(10. 9%). Conclusion There are many causes for bad compliance on taking bromocriptine in patients with macroprolactinomas. The corresponding counterplans can improve the compliance of medicine taking.
Keywords:Macroprolactinomas  Bromocriptine  Compliance  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号